RECRUITING

Developing Fast Pediatric Imaging

Talk to us

Conditions

Pediatric Low-grade GliomasNeuro Oncology

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is evaluating the investigational software for magnetic resonance imaging (MRI) systems and techniques to process magnetic resonance (MR) images

Official Title

Developing Fast Pediatric Imaging

Quick Facts

Study Start:2019-04-15
Study Completion:2027-03-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03761121

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Infants, children and adults who have been diagnosed with Low Grade Glioma
  2. * Healthy volunteers - Children from age 0 to adults with no upper age limit or;
  3. * Diagnosed with LGG and being treated at DFCI;
  1. * Electrical implants such as cardiac pacemakers or perfusion pumps;
  2. * Ferromagnetic implants such as aneurysm clips, surgical clips, prosthesis, artificial hearts, valves with steel parts, metal fragments, shrapnel, tattoos near the eye, or steel implants;
  3. * Ferromagnetic objects such as jewelry or metal clips;
  4. * Women of childbearing age who are seeking to become pregnant, who are breastfeeding, or who suspect they may be pregnant;
  5. * Pre-existing medical conditions including a likelihood of developing seizures or claustrophobic reactions;
  6. * Any greater than normal potential for cardiac arrest

Contacts and Locations

Study Contact

Kawin Setsompop, PhD
CONTACT
617-669-6640
kawin@nmr.mgh.harvard.edu

Principal Investigator

Kawin Setsompop, PhD
PRINCIPAL_INVESTIGATOR
Boston Children Hospital/ Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02214
United States
Boston Children Hospital
Boston, Massachusetts, 02215
United States
Dana Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Boston Children's Hospital

  • Kawin Setsompop, PhD, PRINCIPAL_INVESTIGATOR, Boston Children Hospital/ Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-04-15
Study Completion Date2027-03-01

Study Record Updates

Study Start Date2019-04-15
Study Completion Date2027-03-01

Terms related to this study

Keywords Provided by Researchers

  • Neuro Oncology

Additional Relevant MeSH Terms

  • Pediatric Low-grade Gliomas